News by Emir Zainul

Responding to questions from Najib's lawyer Tan Sri Muhammad Shafee Abdullah, Shahrol said he should not be charged and that he never made a deal with the prosecution and the MACC to testify against Najib.

Lead defence counsel Tan Sri Muhammad Shafee Abdullah alluded during cross-examination today that the Directors Circular Resolution (DCR) pertaining to the conversion of 1MDB's 49% equity stake in PetroSaudi Oil Services Ltd (PSOSL), a subsidiary of PetroSaudi International Ltd (PSI), into fund units was worded in such a way to make it difficult for the board members to understand the processes involved.

10 more patients recovered today, bringing total recoveries to 8,318 cases or 96.3% of overall cases.

Of the 10 new infections, four were imported cases and six were local transmissions involving four Malaysian citizens and two foreigners, said MoH director-general Datuk Dr Noor Hisham Abdullah.

Datuk Dr Noor Hisham Abdullah: If you are infected, that does not mean that you will not be infected again, because the antibody that is built up may not be sufficient to defend against a second infection.

MoH director-general Datuk Dr Noor Hisham Abdullah: In comparison, the recovery rate of Covid-19 cases in Malaysia (96.4%) is among the highest among Asean countries. Besides that, the Covid-19 mortality rate in Malaysia is also among the lowest in the world. No case of Covid-19 death has been reported in the past 12 days.

"We believe the new government is unlikely to proceed with the acquisition of Gamuda's toll highway stakes for RM2.36 billion, given the financial constraints as the federal government deficit is set to rise due to the economic stimulus measures.”

The default arose after it failed to pay the instalment payments on the principal and interest since March this year.

"The appeal period given is two weeks from the date of the court's decision,” the MACC said in a statement today.

Health director-general Datuk Dr Noor Hisham Abdullah said the decision was made after conducting trials using hydroxychloroquine on about 500 Covid-19 patients in the country, but concluded that no significant effect was found on them.